As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Smith & Nephew plc. The largest reported stake is Cevian Capital II GP Limited's, at 14.18%. 5 filings are on record since March 16, 2026 (Schedule 13D/A, July 27, 2026).
Sell to companies like Smith & Nephew plc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Cevian Capital II GP Limited · Sole voting: 119,179,419 · Shared voting: 0 · Sole dispositive: 119,179,419 · Shared dispositive: 0 · SCHEDULE 13D/A, 2026-07-27
- · Holder: Cevian Capital II GP Limited · Percent: 13.09% · SCHEDULE 13D/A
- · Holder: Cevian Capital II GP LTD · Percent: 11.88% · SCHEDULE 13D/A
- · Holder: Cevian Capital II GP LTD · Percent: 10.71% · SCHEDULE 13D/A
- · Holder: Cevian Capital II GP LTD · Percent: 9.6% · SCHEDULE 13D/A
Smith & Nephew plc has 5 Schedule 13D or 13G filings on record since 2026-03-16. 1 holder's latest filing reports 5% or more of ordinary shares, par value $0.20 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Cevian Capital II GP Limited | 14.18% | 119,179,419 | SCHEDULE 13D/A, 2026-07-27 | 2026-07-23 |
Holding shares or following this stake? See who's behind Smith & Nephew plc and the warning signs.
Free to see. No signup.
Keep reading
More on Smith & Nephew plc and the records around it.
Smith & Nephew plc elsewhere on the record
Companies that share a holder
- Cevian Capital II GP LTD also filed stake reports on 1 other company: PEARSON PLC (Sep 2026)
Watch Smith & Nephew plc
Get an email when Smith & Nephew plc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Smith & Nephew plc?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Smith & Nephew plc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Smith & Nephew plc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Cevian Capital II GP Limited | 119,179,419 | 0 | 119,179,419 | 0 | SCHEDULE 13D/A, 2026-07-27 |
The latest filing identifies Smith & Nephew plc by CUSIP 83175M205 and gives its principal executive office as BUILDING 5, CROXLEY PARK, HATTERS LANE, WATFORD, HERTFORDSHIRE (SCHEDULE 13D/A, 2026-07-27).
Source of funds (Item 3)
As of the date hereof, the Reporting Person has purchased for the account of the Cevian Funds an aggregate of 119,179,419 Ordinary Shares for an aggregate consideration (including brokerage commission) of approximately USD $1,673,390,427. The Cevian Funds funded these purchases out of their general working capital. The Ordinary Shares were purchased using British Pounds. For the purposes of this Schedule 13D, a conversion rate of USD $1.33280 for each GBP 1.00 was used.Cevian Capital II GP Limited, SCHEDULE 13D/A, 2026-07-27
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-03-16 | Cevian Capital II GP LTD | 9.6% | SCHEDULE 13D/A |
| 2026-05-04 | Cevian Capital II GP LTD | 10.71% | SCHEDULE 13D/A |
| 2026-06-03 | Cevian Capital II GP LTD | 11.88% | SCHEDULE 13D/A |
| 2026-06-24 | Cevian Capital II GP Limited | 13.09% | SCHEDULE 13D/A |
| 2026-07-27 | Cevian Capital II GP Limited | 14.18% | SCHEDULE 13D/A |
Questions about who owns Smith & Nephew plc
Who owns Smith & Nephew plc?
On this page, one holder's latest ownership filing reports 5% or more of Smith & Nephew plc: Cevian Capital II GP Limited (14.18%, Schedule 13D/A, filed 2026-07-27).
When did Cevian Capital II GP Limited buy into Smith & Nephew plc?
The filings give report dates, not purchase dates. The earliest filing from Cevian Capital II GP Limited on this page is the Schedule 13D/A, filed 2026-06-24, reporting 13.09%; its latest, Schedule 13D/A filed 2026-07-27, reports 14.18%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 5 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Smith & Nephew plc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.